Pain & Expert: Global Pain-assessment: a Prospective Registry
NCT ID: NCT04302935
Last Updated: 2020-03-10
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
100 participants
OBSERVATIONAL
2020-03-02
2021-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Goalsetting in Patients With Chronic Pain: a European Survey
NCT03938142
Opinions of Healthcare Providers About Neuromodulation
NCT05013840
Different Treatments in Chronic Pain Patients.
NCT05768477
Treatment Comparison in Chronic Pain
NCT04261530
Pain Neuroscience Education Combined With Cognition-targeted Motor Control Training
NCT02098005
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
chronic pain patients
Global pain-assessment
Global pain-assessment, based on the ICF framework
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Global pain-assessment
Global pain-assessment, based on the ICF framework
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age =\> 18 years
* Patient has been informed of the study procedures and has given written informed consent
Exclusion Criteria
* Addiction to drugs, alcohol (\>5 units per day)
* Evidence of an active disruptive psychiatric disorder that may impact perception of pain, and/or ability to evaluate treatment outcome as determined by investigator
* Pregnancy
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Moens Maarten
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Moens Maarten
Prof. dr.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Universitair Ziekenhuis Brussel
Jette, Brussels Capital, Belgium
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Lisa Goudman, MSc.
Role: CONTACT
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Maarten Moens
Role: primary
Lisa Goudman
Role: backup
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
P&E
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.